Binding sites for IGF-I, insulin, and GH were localized by in situ binding of 125 I-labelled hormones to the different compartments of the sow ovary. Binding sites for IGF-I were detected in oocytes, granulosa and thecal cells of healthy and atretic follicles as well as in the antrum and the stroma. Competition of 125 I-labelled IGF-I with IGF-I, insulin and an analogue of IGF-I (Long R 3 IGF-I), which allowed discrimination between binding to binding proteins from binding to type-I receptors, suggested that type-I receptors were present in granulosa cells of healthy follicles, whilst binding in other compartments was mainly due to binding proteins. Binding of insulin was revealed in oocytes, granulosa and theca interna cells of healthy preantral and antral follicles, and, to a lesser extent, in theca externa and stromal cells, and was still observed in granulosa cells of atretic follicles. Labelling with 125 Ilabelled bovine GH was demonstrated in oocytes, granulosa cells, theca interna cells, and, although less intense, in theca externa and stromal cells. It disappeared in granulosa cells during atresia. Binding sites for GH were detected at all follicular stages, from preantral to preovulatory stages, but the intensity of labelling in granulosa cells was more intense in preantral than in large follicles. These data support the participation of insulin, GH and IGF-I in oocyte maturation, follicular growth and stromal cell function in swine.
Introduction
Ovarian follicular growth and differentiation is controlled by pituitary gonadotrophins, luteinizing hormone and follicle-stimulating hormone, and by local factors, such as steroids and growth factors. In numerous species, evidence has been provided that nutrition may influence ovarian function, and in pigs some observations suggested that nutritional effects alter folliculogenesis, not only through gonadotrophin-mediated effects, but also through direct effects at the ovarian level (reviewed by Cosgrove & Foxcroft 1996 , Cox 1997 . Insulin, insulin-like growth factor-I (IGF-I) and growth hormone (GH) have been proposed as metabolic mediators of these latter effects for several reasons. First, their systemic concentrations are closely dependent upon nutrition. Secondly, they may stimulate or inhibit ovulation and increase the ovulation rate when administrated to prepubertal or cyclic gilts or to reproductive sows (insulin: Cox et al. 1987 , Ramirez et al. 1997 , IGF-I: Okere et al. 1996 , GH: Kirkwood et al. 1988 . Thirdly, in vitro studies in various species provided evidence that these hormones can alter the activity of follicular cells, either in synergy with gonadotrophins, or alone. Thus, GH accelerates in vitro differentiation of cultured granulosa cells, mainly by amplification of gonadotrophin action ( Jia et al. 1986 , Hsu & Hammond 1987 , but GH alone may also stimulate steroid production (Hsu & Hammond 1987 , Manson et al. 1990 ). Insulin and IGF-I stimulate granulosa cell mitogenesis and steroidogenesis of follicular cells (Adashi et al. 1985) . These effects are mediated by specific receptors and these receptors, or their mRNAs, have been detected in the ovaries of numerous species, including the pig (Giudice 1992) . However, in this latter species, localization of these receptors in the different ovarian compartments has never been fully described. Thus, the aim of the present study was to localize the binding sites for GH, insulin and IGF-I in follicles and corpora lutea in the female pig.
Materials and Methods

Materials
Large White gilts (INRA, Saint-Gilles, France) had their oestrous cycles synchronized with a progesterone agonist, Regumate (Roussel Uclaf, Romanville, France). Ovaries were removed by laparotomy conducted under general anaesthesia at days 4 (late follicular phase, three sows) or 10 (early luteal phase, two sows) after the last day of treatment. Ovaries of two gestating gilts were removed at slaughter at day 104 of gestation. They were coated with cryoprotectant embedding medium (Tissue-Tek, Miles Laboratories, Elkhart, IN, USA), frozen in liquid nitrogen and stored at 80 C.
Purified bovine GH (bGH) (USDA-bGH-B1; USDA Animal Hormone Program, Beltsville, MD, USA) was iodinated by the chloramine-T method to a specific activity of 40-50 µCi/µg. This radioligand was used rather than porcine GH (pGH) because it has been previously shown that specific binding in porcine tissue was higher with 125 I-labelled bGH than with homologous 125 Ilabelled pGH (Breier et al. 1989) . bGH was also used as unlabelled ligand. Recombinant human (rh) IGF-I and IGF-II, and Long R 3 IGF-I (LR 3 IGF-I), a potent analogue of rhIGF-I, were supplied by GroPep Pty Ltd (Adelaide, SA, Australia). rhIGF-I was iodinated by the chloramine-T method to a specific activity of 150-160 µCi/µg. Iodinated porcine insulin (INSI-TRA, approximate specific activity 300 µCi/µg) was purchased from CIS Bio International (Gif-sur-Yvette, France) and unlabelled insulin from porcine pancreas from Sigma (St Louis, MO, USA).
Binding assays on histological sections
Binding of iodinated hormones was detected by an autoradiographic method adapted from Monget et al. (1989) . Frozen ovaries were cut into 8 µm thick serial sections with a cryomicrotome. After fixation for 10 min at 4 C in 4% paraformaldehyde-PBS (0·01 M, pH 7·4) and three subsequent washes in cold PBS, sections were stored at 4 C for a maximum of 48 h and then circled with a special pen (PAP pen, Labonord, Templemars, France). They were incubated for 30 min at 4 C in 200 µl incubation buffer, then overnight at 4 C in 200 µl incubation buffer containing the 125 I-labelled ligand (10 5 c.p.m./100 µl). The incubation buffers were Tris 25 mM, CaCl 2 10 mM, BSA 0·5%, NaN 3 0·02%, pH 7·4 for bGH and Tris 50 mM, MgCl 2 5 mM, BSA 0·5%, NaN 3 0·02%, pH 7·4 for IGF-I and insulin. To determine nonspecific binding, for each ligand tested, an adjacent serial section of ovary was incubated with an excess of unlabelled ligand (400, 300 and 200 ng/100 µl for bGH, IGF-I and insulin respectively). To discriminate IGF-I binding to IGFbinding proteins (IGFBPs) from binding to type-I receptor ('IGF-I receptor'), displacements were performed with various ligands. Indeed, it has been demonstrated in several species that IGF-I binding on receptors may be completely displaced by an excess of IGF-I, IGF-II or LR 3 IGF-I, or partially displaced by a large amount of insulin, whereas IGF-I binding to IGFBPs could not be removed by LR 3 IGF-I (Francis et al. 1992) or insulin, even in large excess (reviewed by Giudice 1992) . After incubation, sections were washed three times in PBS, postfixed in 3% glutaraldehyde-PBS, washed in PBS and air dried for 2 h. For autoradiography, they were dipped into Kodak NTB2 emulsion diluted 1:1 with distilled water, air dried and exposed at 4 C for 4 or 10 days. The emulsion was developed and fixed according to the manufacturer's instructions, then the sections were counterstained with Harris' haematoxylin solution and mounted. Sections were observed using a Leitz Orthoplan microscope (Leica, Rueil Malmaison, France) in darkfield to see silver grains or in brightfield to see cells. The intensity of staining for each compartment was compared within sections or within experiments.
To assess the quality of the follicles, some sections were fixed in methanol-formaldehyde-acetic acid (80:15:5) and stained with Feulgen reagent. Follicles were classified as early atretic and atretic when few (at least four) or numerous pycnotic granulosa cells were found on the section respectively. When almost all granulosa cells were pycnotic, follicles were classified as late atretic.
Hormone binding to follicles was examined in ovaries taken 4 days after Regumate treatment (during the follicular phase) and binding to corpora lutea in ovaries removed 10 days after the treatment (during the early luteal phase) and during late gestation.
Results
Binding sites for IGF-I
Binding sites for IGF-I were widespread in the ovary. They were detected in all the oocytes examined (n=20). They were also observed in granulosa cells and theca interna and externa cells of healthy and atretic follicles as well as in the antrum, in corpora lutea and in the stroma (Figs 1, 2 and 3; Table 1 ).
Binding of 125 I-labelled IGF-I in granulosa cells of healthy follicles was partially displaced by LR 3 IGF-I (Fig. 2) . Binding in thecal cells (interna and externa) of healthy and atretic follicles and in granulosa cells of atretic follicles was not displaced, or only poorly displaced, by LR 3 IGF-I. In corpora lutea of gestation, IGF-I labelling in large luteal cells was displaced by IGF-I (completely) and IGF-II (partially), and was poorly displaced by LR 3 IGF-I or by insulin in excess (Fig. 3) .
Specific binding sites for insulin
A slight labelling was observed in six out of nine oocytes examined. Labelling was more intense in granulosa and theca interna cells of healthy follicles, and less marked in theca externa and stroma ( Fig. 4 ; Table 1 ). In atretic follicles, binding was observed in both granulosa cells and thecal cells (Fig. 4) . Labelling was present in luteal cells of cyclic or gestating corpora lutea (Fig. 5) . No labelling was found in the antrum.
Specific binding sites for GH
Specific labelling was found in granulosa, thecal and stromal cells (Fig. 6, Table 1 ). All the oocytes observed were also labelled (n=30, Fig. 6 ). In healthy follicles, both granulosa and thecal cells presented binding sites for GH (Fig. 6) . In early atretic follicles, granulosa cells still presented a clear labelling, which disappeared in late atretic follicles (Fig. 6) . Binding sites were detected in all follicular stages, from preantral to preovulatory stages. However, the intensity of labelling in granulosa cells was more intense in preantral follicles than in large follicles. 
Discussion
To our knowledge, no attempt to localize binding sites for insulin and GH in the different compartments of the swine ovary has been previously reported. Therefore, we have localized simultaneously binding sites for IGF-I, insulin and GH by in situ binding on frozen ovarian sections. Our results show the presence of binding sites for IGF-I in oocytes, granulosa and thecal cells (interna and externa) of preantral follicles, antral healthy follicles and atretic follicles, as well as in the stroma. Since IGF-I binding on granulosa cells of healthy follicles was partially, but clearly, displaced by the IGF-I analogue LR 3 IGF-I, these binding sites are likely to be, at least in part, type-I receptors. In pigs, previous studies have revealed two classes of specific IGF-I-binding sites in granulosa cells from small, medium and large follicles (Maruo et al. 1988 ) and the expression of IGF-I receptor mRNAs in granulosa cells of developing and dominant healthy follicles (Zhou et al. 1996) . In other cell types (thecal cells of healthy and atretic follicles and granulosa cells of atretic follicles) and in the antrum, our data show that IGF-I binding was not displaced by LR 3 IGF-I, suggesting the presence of binding proteins, rather than of receptors. This result is consistent with the localization of IGF-I receptor mRNAs exclusively in granulosa cells of healthy follicles (Zhou et al. 1996) . However, it contrasts with the data of Caubo et al. (1989) , who demonstrated the presence of specific IGF-I receptors in thecal cells from large follicles. Moreover, IGF-I has been demonstrated to modulate in vitro steroidogenesis of porcine thecal cells (Caubo et al. 1989 , Engelhardt et al. 1991 . Using our method, we cannot exclude that a minor population of IGF-I binding in thecal cells and in apoptotic granulosa cells was due to specific receptors. Concerning IGFBPs in swine ovaries, the expression of IGFBP-2 and -4 mRNAs has been reported in granulosa and thecal cells throughout the follicular development (Zhou et al. 1996) , and the presence of IGFBP-2, -3 and -4 has been demonstrated in follicular fluid, IGFBP-2 being most related to atresia and IGFBP-3 to preovulatory maturation (Mondschein et al. 1991 , Grimes et al. 1994 .
The labelling with IGF-I observed in corpora lutea, poorly displaced by LR 3 IGF-I or insulin, indicates the presence of large amounts of binding proteins and low levels of receptors in corpora lutea. Similarly, low expression of IGF-I receptor mRNAs and high expression of IGFBPs have been reported in porcine corpora lutea from the luteal phase (Zhou et al. 1996) .
We demonstrated the presence of binding sites for insulin in the ovaries of pigs. Since insulin is known to bind insulin receptors with high affinity and type-I receptors with low affinity, and to have no affinity for type-II receptors and IGFBPs (reviewed by Giudice 1992) , and since unlabelled insulin completely competed for the labelled ligand (present data), these binding sites represent mainly specific receptors for insulin. They were localized in stroma and in oocytes, granulosa and thecal cells (interna and externa) of preantral, small antral and large follicles and in luteal cells. Similarly, insulin receptors or corresponding mRNAs have been reported in human ovary in stroma, granulosa and theca cells and oocytes of growing follicles (Poretsky et al. 1985 , El-Roeiy et al. 1993 , Samoto et al. 1993 , as well as in rat and human luteal cells (Ladenheim et al. 1984 , Samoto et al. 1993 . In pigs, the presence of insulin receptors has been previously investigated only in granulosa cells and their presence has been detected (Rein & Schomberg 1982 , Otani et al. 1985 . A role for insulin has been described in follicular and luteal steroidogenesis (Veldhuis et al. 1983 , Otani et al. 1985 , Caubo et al. 1989 , Morley et al. 1989 , in oocyte maturation (Tsafiri & Channing 1975) and in glucose metabolism of granulosa cells (Otani et al. 1985 , Weber & LaBarbera 1988 . In our study, atretic follicles also presented a clear labelling in granulosa and thecal cells. In women, insulin receptor mRNAs have been detected in pycnotic granulosa cells (El-Roeiy et al. 1993) , whereas no immunoreactivity for insulin receptor has been revealed in atretic follicles (Samoto et al. 1993) . The presence of insulin receptor in granulosa and theca interna of atretic and healthy follicles, as well as in corpora lutea of both stages, may suggest that this receptor is constitutively expressed in pigs.
We demonstrated that bGH binding sites presented a widespread distribution in the swine ovary. The use of bGH for in situ binding avoids confusion between somatotrophic and lactogenic sites, since bGH binds only GH sites without affinity for prolactin binding sites (Posner et al. 1974 , Ranke et al. 1976 . The method, however, did not allow unequivocal distinction between binding to GH receptor and binding to GH-binding proteins (GHBPs). The observation of a single mRNA transcript encoding for GH receptor in porcine liver and muscle supports the hypothesis that GHBPs arise from GH receptors by proteolysis (Schnoebelen-Combes et al. 1996) . This suggests that the presence of GHBPs is related to the presence of GH receptors. Moreover, 125 I-labelled bGH specific binding has been observed in microsomal membrane proteins of whole ovaries and Scatchard analysis has revealed the presence of a single binding site of high affinity (K a =2·8-3·4 10 9 l/mol, data not shown). We may therefore argue that binding sites detected in the present study are, at least in part, GH receptors.
Our data show binding sites for bGH in follicular cells, as well as in oocytes of preantral and small antral follicles. The presence of GH receptor mRNAs has been recently reported in oocytes of preantral and small antral follicles in the ewe (Eckery et al. 1997 ) and the cow (Kölle et al. 1998) . While receptors for GH or mRNAs have been previously localized in the corpus luteum of all species tested (in rats, Lobie et al. 1990; in heifers, Lucy et al. 1993a; in humans, Sharara & Nieman 1994; in pigs, Yuan & Lucy 1996) , various data have been reported concerning follicular localization. In the present study, GH binding sites were detected in granulosa and thecal cells of follicles from the preantral to the preovulatory stage. In heifers, Lucy et al. (1993a) observed neither immunoreactivity nor mRNAs for GH receptors in follicles of any size, whereas Kölle et al. (1998) reported the expression of GH receptor mRNAs and protein in oocyte and granulosa cells of primary and secondary follicles and in the cells of the cumulus oophorus in tertiary follicles. In humans, mRNAs coding for GH receptor were detected in granulosa cells of antral and dominant follicles, but not in preantral follicles, theca interna and externa cells, oocytes or stroma (Sharara & Nieman 1994) . In adult rats, only moderate immunoreactivity for GH receptors appeared in follicles (Lobie et al. 1990 ). In pigs, Yuan & Lucy (1996) failed to detect any GH receptor mRNAs in small antral follicles in porcine ovary on day 10 of the oestrous cycle, whilst in sheep Eckery et al. (1997) reported mRNAs for GH receptors in granulosa cells of small antral follicles.
In cattle, Webb et al. (1994) have suggested that the increase in the number of small-or medium-sized follicles following administration of GH (Gong et al. 1991 , Lucy et al. 1993b ) was more likely due to the increase in either IGF-I, insulin or both than to a direct effect of GH on follicles. Administration of GH to cyclic gilts has been demonstrated to increase ovulation rate (Kirkwood et al. 1988 ) and the number of medium-sized, but not of small-sized, antral follicles (Echternkamp et al. 1994) . The presence of GH binding sites in follicles suggests that, in gilts, GH effects may be mediated by GH receptors and not necessarily by IGF-I action at the ovarian level. Cattle and pigs may thus differ with respect to the action of GH on follicular growth. In the present study, the intensity of GH binding on granulosa cells seemed to be inversely related to the follicular size, being strong in preantral and small antral follicles and barely detectable in preovulatory follicles. Moreover, these binding sites are undetected in atretic follicles. This may imply that GH has a direct role, particularly important in early stages of folliculogenesis, when follicular growth does not require the action of gonadotrophins (Driancourt et al. 1995) .
In conclusion, present data support the participation of IGF-I, insulin and GH in the process of follicular growth and suggest that their action is, at least in part, mediated through their specific receptors.
